• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vericel Corporation (NQ: VCEL )

    45.87 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 45.87
    Bid (Size) 18.35 (2)
    Ask (Size) 72.93 (1)
    Prev. Close 45.87
    Today's Range 45.87 - 45.87
    52wk Range 30.18 - 53.05
    Shares Outstanding 46,631,158
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
    From Vericel Corporation
    Via GlobeNewswire
    Analyst Scoreboard: 5 Ratings For Vericel
    Via Benzinga

    Performance

    YTD
    +31.51%
    +31.51%
    1 Month
    -13.29%
    -13.29%
    3 Month
    +3.64%
    +3.64%
    6 Month
    +30.39%
    +30.39%
    1 Year
    +42.36%
    +42.36%

    More News

    Read More
    It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
    Via Talk Markets
    A Closer Look at 4 Analyst Recommendations For Vericel
    Via Benzinga
    Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
    From Vericel Corporation
    Via GlobeNewswire
    Earnings Scheduled For February 29, 2024
    Via Benzinga
    HC Wainwright & Co. Maintains Buy Rating for Vericel: Here's What You Need To Know
    Via Benzinga
    Analyst Ratings for Vericel
    Via Benzinga
    Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
    From Vericel Corporation
    Via GlobeNewswire
    3 Top Pharma Stocks for Investors Betting on a Biotech Boom
    Via InvestorPlace
    Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
    From Vericel Corporation
    Via GlobeNewswire
    5 medical stocks growing earnings by triple digits
    Via MarketBeat
    Topics Economy
    Exposures Economy
    Analyst Ratings for Vericel
    Via Benzinga
    Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
    From Vericel Corporation
    Via GlobeNewswire
    Vericel Corp. (NASDAQ: VCEL) Sets New 52-Week High in Tuesday Session
    Via Investor Brand Network
    Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
    From Vericel Corporation
    Via GlobeNewswire
    Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024
    From Vericel Corporation
    Via GlobeNewswire
    Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development
    Via Benzinga
    3 Biotech Stocks That Could Boom or Bust by 2025
    Via InvestorPlace
    3 Strong Buy Stocks Set to Take Off in the Coming Months
    Via InvestorPlace
    Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
    From Vericel Corporation
    Via GlobeNewswire
    Vericel to Present at the Stephens Annual Investment Conference
    From Vericel Corporation
    Via GlobeNewswire
    Earnings Scheduled For November 8, 2023
    Via Benzinga
    Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023
    From Vericel Corporation
    Via GlobeNewswire
    Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid
    From Vericel Corporation
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.